Star Combo Pharma (ASX:S66) ROCE % : 2.01% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Star Combo Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Star Combo Pharma's annualized ROCE % for the quarter that ended in Dec. 2024 was 2.01%.

Star Combo Pharma ROCE % Historical Data

The historical data trend for Star Combo Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Combo Pharma ROCE % Chart

Star Combo Pharma Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROCE %

Get a 7-Day Free Trial

-1.42

-16.09

-2.30

-8.45

3.16

Star Combo Pharma Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial									-22.04	5.06	1.61	4.69	2.01

Star Combo Pharma ROCE % Calculation

Star Combo Pharma's annualized ROCE % for the fiscal year that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2024 )		(A: Jun. 2023 )		(A: Jun. 2024 )
	=	1.197	/	( ( (42.227 - 4.332)	+	(42.816 - 4.872) )	/ 2 )
	=	1.197	/	( (37.895	+	37.944)	/ 2 )
	=	1.197	/	37.9195
	=	3.16 %

Star Combo Pharma's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	0.764	/	( ( (42.816 - 4.872)	+	(43.319 - 5.173) )	/ 2 )
	=	0.764	/	( ( 37.944	+	38.146 )	/ 2 )
	=	0.764	/	38.045
	=	2.01 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

Star Combo Pharma (ASX:S66) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Star Combo Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Star Combo Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Combo Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Star Combo Pharma Ltd (ASX:S66) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

171 - 177 Woodpark Road, Smithfield, Sydney, NSW, AUS, 2164

Website

https://www.starcombo.com.au

Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.

Star Combo Pharma Headlines

No Headlines